FORMULATION AND PENETRATION TESTING OF ETHOSOME AZELAIC ACID ON ABDOMINAL SKIN WHITE MALE RATS (RATTUS NORVEGICUS) WITH FRANZ DIFFUSION CELL

Novi Nurleni; Iskandarsyah Iskandarsyah; Ahmad Aulia

doi:10.22159/ajpcr.2018.v11i4.22193

Authors

Novi Nurleni Department of Pharmacy, Universitas Indonesia, Depok, Indonesia.
Iskandarsyah Iskandarsyah Department of Pharmacy, Universitas Indonesia, Depok, Indonesia.
Ahmad Aulia Department of STIFI Bhakti Pertiwi, South Sumatera, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i4.22193

Keywords:

Azelaic acid, Penetration enhancer with vesicles ethosome, Franz diffusion cell

Abstract

Â Objective: Development of transdermal drug delivery systems has several advantages, especially drugs to have a poor penetration of stratum corneum in the skin. Azelaic acid has been proven bactericidal and bacteriostatic to acnes bacteria (Propionibacterium acnes). Azelaic acid products in market as cream and gel can only penetration in stratum corneum about 4% of the dosage used. Thus, it is necessary to increase the penetration of azelaic acid to formulate into a carrier system such as ethosome.

Methods: Manufacture of suspension ethosom azelaic acid using thin layer hydration method or classical method. Suspension ethosom of azelaic acid to obtained subsequent freeze dried before formulated in cream preparation. After that, the penetration test for ethosom cream and non ethosom cream of azelaic acid with Franz Diffusion Cell.

Results: Optimization formulation ethosom of azelaic acid with variations concentration of ethanol 30%, 35% and 40%. Ethosome with 35% ethanol had entrapment efficiency higher than 30% and 40% ethanol as 94.48Â±0.14% and had smaller particle size 179.3Â±2.23 nm. Penetration test for ethosome cream and non-ethosome cream of azelaic acid showed that cumulative amount was 1334.074Â±27.086 Î¼g/cm2 h and 491.032Â±3.935 Î¼g/cm2 h.

Conclusion: Ethosome cream of azelaic acid has better penetration capabilities than non-ethosom cream of azelaic acid.

Downloads

Download data is not yet available.

References

Mustacich D, Powis G. Thioredoxin reductase. J Biochem 2000;346:1-8.

Webster GE. Acne. Current problems in dermatology. Vol. 8. New York, NY: Mosby; 1996.

Esposito E, Menegatti E, Cortesi R. Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study. J Cosmet Sci 2004;55:253-64.

Burchacka E, Potaczek P, PaduszyÅ„ski P, KarÅ‚owicz-Bodalska K, Han T, Han S, et al. New effective azelaic acid liposomal gel formulation of enhanced pharmaceutical bioavailability. Biomed Pharmacother 2016;83:771-5.

Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther 1998;20:945-59.

Nico S, Vicanova J, Pavel S. The hunt for natural skin whitening agents. Int J Mol Sci 2009;10:5326-49.

Dessinioti C, Pavlidis A, Katsambas AD. Melasma. Pigment Disord 2014;1:1.

Food and Drug Administration. Guidance for Industry Guidance for Industry Nonsteril Semisolid Dosage Forms; 1997. p. 19-24.

FDA. Available from: https://www.drugs.com/pro/azelex.html.

Gollcink H. Azelaic acid-pharmacology, toxicology and mechanisms of action on keratinization in vitro and in vivo. J Dermatol Treadment 2009;4:3-7.

Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14.

Mather K, Ryan SC. Topical Vehicles Containing Solubilized and Stabilized Azelaic Acid. USA: US Patent 1999;5:925-679.

Rekesh R, Anoop KR. Ethosome for transdermal and topical drug delivery. Int J Pharm Pharm Sci 2012;4:17-24.

Kishore M, Jayakash M, Reddy TV. Spectrophotometric determination of azelaic acid in pharmaceutical formulations. J Pharm Res 2010;3:3090-2.

Kadam TV, Darekar AB, Gondkar SB, Saudagar RB. Development and validation of spectrophotometric method for determination of azelaic acid. Asian J Res Pharm Sci 2015;5:83-5.

Dave and Pareek. Ethosome: A novel approach of transdermal drug delivery system. Int J Adv Res Pharm BioSci 2012;2:439-52.

Afifah T. Formulasi Lipstik Menggunakan Transfersom Xanton dengan Metoda Hidrasi Lapis Tipis. Fakultas Farmasi Universitas Indonesia; 2015.

Hastri M. Uji Penghambatan Tirosinase Secara In Vitro Serta Stabilitas Fisik dan Stabilitas Kimia Sediaan Krim Yang Mengandung Asam Azelat. Skripsi FMIPA UI; 2012.

Ankita M, Ravikumar P. Development and evaluation of azelaic acid based ethosomes for topical delivery for the treatment of acne. Indian J Pharm Educ Res 2016;50:S232-43.

Sintov AC, Botner S. Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int J Pharm 2006;311:55-62.

Akiladevi D, Basak S. Ethosomes a noninvasive approach for transdermal drug delivery. Int J Curr Pharm Res 2010;2:1-4.

Rajab NA, Rassol AA, Assaf SM, Sallam AA. Preparation and evaluation of fentanyl transdremal patches using lidocaine as a model drug and azelaic acid as a penetration enhancer. Int J Pharm Pharm Sci 2014;6:615-20.

Mohammed MI, Makky AM, Abdellatif MM. Formulation and characterization of ethosomes bearing vancomycin hydrochloride for transdermal delivery. Int J Pharm Pharm Sci 2014;6:190-4.